Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

GNF 2

Name GNF 2
Supplier R&D Systems
Catalog 4399
Prices $225.00, $925.00
Sizes 10 mg, 50 mg
Cas Number 778270-11-4
Chemical Name 3-[6-[[4-(Trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamide
Formula C18H13F3N4O2
Molecular Weight 374.32
Purity >98%
Supplier Page Shop

Product References

Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. - Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.

Zhang J, Adrian FJ, Jahnke W, Cowan-Jacob SW, Li AG, Iacob RE, Sim T, Powers J, Dierks C, Sun F, Guo GR, Ding Q, Okram B, Choi Y, Wojciechowski A, Deng X, Liu G, Fendrich G, Strauss A, Vajpai N, Grzesiek S, Tuntland T, Liu Y, Bursulaya B, Azam M, Manley PW, Engen JR, Daley GQ, Warmuth M, Gray NS. Nature. 2010 Jan 28;463(7280):501-6.

Allosteric inhibitors of Bcr-abl-dependent cell proliferation. - Allosteric inhibitors of Bcr-abl-dependent cell proliferation.

Adrian FJ, Ding Q, Sim T, Velentza A, Sloan C, Liu Y, Zhang G, Hur W, Ding S, Manley P, Mestan J, Fabbro D, Gray NS. Nat Chem Biol. 2006 Feb;2(2):95-102. Epub 2006 Jan 15.

Inhibitors of Bcr-abl... breaking new ground again. - Inhibitors of Bcr-abl... breaking new ground again.

Ohren JF, Sebolt-Leopold JS. Nat Chem Biol. 2006 Feb;2(2):63-4.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved